Tyrosinemia type I: A clinico-laboratory case report

Indian Journal of Pediatrics

Volumn 71, Issue 10, 2004, Pages 929-932

  Karnik, Deepali ^a   Thomas, Niranjan ^a   Eapen, C E ^a   Jana, A K ^a   Oommen, A ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Amino acids; Inherited metabolic disease; Tyrosinemia type I

Indexed keywords

ALPHA FETOPROTEIN; AMINOLEVULINIC ACID; CARNITINE; CYANOCOBALAMIN; FUMARYLACETOACETASE; ISOMERASE; MALEYLACETOACETATE ISOMERASE; METHIONINE; NITISINONE; PYRIDOXINE; RIBOFLAVIN; SUCCINYLACETONE; THIAMINE; TYROSINE; UNCLASSIFIED DRUG;

AMINOACIDURIA; ARTICLE; BLOOD LEVEL; CASE REPORT; CLINICAL FEATURE; DISEASE CLASSIFICATION; ENZYME DEFICIENCY; FEMALE; HUMAN; LABORATORY DIAGNOSIS; LIVER DYSFUNCTION; NEWBORN; TYROSINEMIA;

EID: 9644270633     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02830839     Document Type: Article

References (12)

1. Lindblad B, Lindstedt S, Steen G. On the enzymatic defects in hereditary tyrosinemia. Proc Natl Acad Sci (USA) 1977; 74: 4641-4645.
2. St-Louis M, Tanguay RM. Mutations in the fumarylacetoacetate hydrolase gene causing hereditary tyrosinemia type I. Overview. Hum Mutat 1997; 9: 291.
3. De Brackeleer M. Hereditary disorders in Saguenay-Lac-St-Jean (Quebec, Canada) Hum Hered 1991; 41: 141.
4. Kvittingen E. Hereditary tyrosinemai type I - an overview. Scand J Clin Lab Invest 1986; 46: 27-34.
5. Grompe M. The pathophysiology and treatment of hereditary tyrosinemia type I. Seminars in Liver Disease 2001; 21: 563-571.
6. Mitchell GA, Larochelle J, Lambert M et al. Neurologic crisis in hereditary tyrosinemia. N Engl J Med 1990; 322: 432-437.
7. Krywawych S. Thin layer chromatography of non-volatile organic acids in clinical chemistry. Clin Chem Acta 1979; 91: 353-361.
8. Grenier A, Lescault A, Laberge C, Gagne R, Marner O. Detection of succinylacetone and use of its measurement in mass screening for hereditary tyrosinemia. Clin Chem Acta 1982; 123: 93-99.
9. Mitchell G, Grompe M, Lambert M, Tanguay RM. In Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. Chapter 79, Vol II pp 1777-1805 8th edn. New York. McGraw-Hill.
10. Mitchell GA, Russo PA, Dubois J, Alvarez F. In Suchy FJ, Sokol J, Balistreri WF, eds. Tyrosinemia, Chapter 29, Liver Disease in Children. 2nd edn. Philadelphia, Lippincott Williams & Wilkins, (2001).
11. Berger R, Michals K, Galbraeth J, Matalon R. Tyrosinemia type Ib caused by malylacetoacetate isomerase deficiency: a new enzyme defect. Pediatr Res 1988; 23: 328A.
12. Holme E, Lindstedt S. Tyrosinemia type 1 and NTBC (2(2-nitro-4-trifluoro- methylbenzyol)-1,3 cyclohexanedione). J Inherit Metab Dis 1998; 21: 507-517.